News Focus
News Focus
icon url

postes

09/10/21 8:45 AM

#353970 RE: couldbebetter #353966

A hostile bid was slightly plausible under Thero…… the vast vast majority of BO today especially in drugs are friendly…… KM has the shareholders back.
icon url

Meowza

09/10/21 8:52 AM

#353971 RE: couldbebetter #353966

Amarin has always gotten gobs of manufactured negative press. Of course it was on BP's radar.
icon url

rosemountbomber

09/10/21 8:53 AM

#353972 RE: couldbebetter #353966

Imagine what Pfizer could
do with Vascepa for CVD.



Could, assuming this is the reason for the PFE deal with HLS, Pfizer is not imagining what they could do with V, they actually want to find out first. As someone here mentioned recently, there may be a lot of things to overcome to get V to the sales level we think (i.e. supplements, docs preconditioned to recommend supplements instead of V, docs acceptance of V, etc.) and PFE wants to be sure.